This review is a summary of a presentation given by Associate Professor Surbhi Sidana at the
Johnson & Johnson H3 Medical Education Symposium held in Melbourne, in March 2026. The
talk discussed setting up a treatment programme offering CAR T and BsAb therapy, with a
specific focus on how to minimise treatment-related adverse effects.
Please login below to download this issue (PDF)